Literature DB >> 21439685

[Non dietetic environmental risk factors in prostate cancer].

J Ferrís-I-Tortajada1, O Berbel-Tornero, J Garcia-I-Castell, J A López-Andreu, E Sobrino-Najul, J A Ortega-García.   

Abstract

INTRODUCTION: The aim is to update and disclose the main environmental risk factors, excluding dietary factors, involved in the etiopathology of prostate cancer. MATERIALS AND
METHOD: Bibliographic review of the last 25 years of non-dietary environmental risk factors associated with prostate cancer between 1985 and 2010, obtained from MedLine, CancerLit, Science Citation Index and Embase. The search profiles were Environmental Risk Factors/Tobacco/Infectious-Inflammatory Factors/Pesticides/Vasectomy/Occupational Exposures/Chemoprevention Agents/Radiation and Prostate Cancer.
RESULTS: While some non-dietary environmental risk factors increase the risk of acquiring the disease, others decrease it. Of the former, it is worth mentioning exposal to tobacco smoke, chronic infectious-inflammatory prostatic processes and occupational exposure to cadmium, herbicides and pesticides. The first factors that reduce the risk are the use of chemopreventive drugs (Finasterida, Dutasteride) and exposure to ultraviolet solar radiation. With the current data, a vasectomy does not influence the risk of developing the disease.
CONCLUSIONS: The slow process of prostate carcinogenesis is the final result of the interaction of constitutional risk and environmental factors. Non-dietary environmental factors play an important role in the etiopathology of this disease. To appropriately assess the risk factors, extensive case studies that include all the possible variables must be analysed.
Copyright © 2010 AEU. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439685      PMCID: PMC5176024          DOI: 10.1016/j.acuro.2010.12.010

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  35 in total

1.  Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer.

Authors:  Lennart Hardell; Swen-Olof Andersson; Michael Carlberg; Louise Bohr; Bert van Bavel; Gunilla Lindström; Helen Björnfoth; Claes Ginman
Journal:  J Occup Environ Med       Date:  2006-07       Impact factor: 2.162

2.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

3.  Cancer among farmers: a meta-analysis.

Authors:  J Acquavella; G Olsen; P Cole; B Ireland; J Kaneene; S Schuman; L Holden
Journal:  Ann Epidemiol       Date:  1998-01       Impact factor: 3.797

4.  The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study.

Authors:  D Boers; M P A Zeegers; G M Swaen; Ij Kant; P A van den Brandt
Journal:  Occup Environ Med       Date:  2005-08       Impact factor: 4.402

5.  Smoking and risk of total and fatal prostate cancer in United States health professionals.

Authors:  E Giovannucci; E B Rimm; A Ascherio; G A Colditz; D Spiegelman; M J Stampfer; W C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-04       Impact factor: 4.254

Review 6.  Cadmium and prostate cancer: a critical epidemiologic analysis.

Authors:  Abe E Sahmoun; L Douglas Case; Sharon A Jackson; Gary G Schwartz
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

7.  Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia).

Authors:  Lin Fritschi; Geza Benke; Ann M Hughes; Anne Kricker; Claire M Vajdic; Andrew Grulich; Jennifer Turner; Samuel Milliken; John Kaldor; Bruce K Armstrong
Journal:  Cancer Causes Control       Date:  2005-06       Impact factor: 2.506

8.  Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.

Authors:  Richard Olivier Fourcade; Agnes Benedict; Libby K Black; Michael E Stokes; Antonio Alcaraz; Ramiro Castro
Journal:  BJU Int       Date:  2010-01       Impact factor: 5.588

9.  Occupation and cancer - follow-up of 15 million people in five Nordic countries.

Authors:  Eero Pukkala; Jan Ivar Martinsen; Elsebeth Lynge; Holmfridur Kolbrun Gunnarsdottir; Pär Sparén; Laufey Tryggvadottir; Elisabete Weiderpass; Kristina Kjaerheim
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

10.  XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.

Authors:  Robert Schlaberg; Daniel J Choe; Kristy R Brown; Harshwardhan M Thaker; Ila R Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-08       Impact factor: 11.205

View more
  5 in total

1.  Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.

Authors:  Qiaoxin Li; Yao Zhu; Jing He; Mengyun Wang; Meiling Zhu; Tingyan Shi; Lixin Qiu; Dingwei Ye; Qingyi Wei
Journal:  Mol Biol Rep       Date:  2013-01-01       Impact factor: 2.316

Review 2.  Constitutional and occupational risk factors associated with bladder cancer.

Authors:  J Ferrís; J Garcia; O Berbel; J A Ortega
Journal:  Actas Urol Esp       Date:  2013-05-09       Impact factor: 0.994

Review 3.  Review of Vasectomy Complications and Safety Concerns.

Authors:  Fang Yang; Junjun Li; Liang Dong; Kun Tan; Xiaopeng Huang; Peihai Zhang; Xiaozhang Liu; Degui Chang; Xujun Yu
Journal:  World J Mens Health       Date:  2020-07-30       Impact factor: 5.400

4.  Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology.

Authors:  Samaneh Farashi; Thomas Kryza; Jyotsna Batra
Journal:  Genes (Basel)       Date:  2020-05-08       Impact factor: 4.096

Review 5.  Prostate cancer biology & genomics.

Authors:  Hayley Whitaker; Joseph O Tam; Martin J Connor; Alistair Grey
Journal:  Transl Androl Urol       Date:  2020-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.